INTERNATIONAL PATENT: VISIRNA THERAPEUTICS (SUZHOU) CO., LTD. FILES APPLICATION FOR "DOUBLE-STRANDED OLIGONUCLEOTIDE AGENTS AND USES THEREOF"

GENEVA, Feb. 3 -- VISIRNA THERAPEUTICS (SUZHOU) CO., LTD. (Unit 401, Building 5, Block B, Phase III, Biomedical Industrial Park, No. 99 Jingu Road, Suzhou Area, China (Jiangsu) Pilot Free Trade ZoneSuzhou, Jiangsu 215028) filed a patent application (PCT/CN2024/106419) for "DOUBLE-STRANDED OLIGONUCLEOTIDE AGENTS AND USES THEREOF" on Jul 19, 2024. With publication no. WO/2025/021034, the details related to the patent application was published on Jan 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZOU, Xiaoming (Unit 401, Building 5, Block B, Phase III, Biomedical Industrial Park, No. 99 Ji...